Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2012-04-30 | Mr. Cohen is an independent international business consultant and is Chairman and President of Kramex Company, a privately owned consulting firm. |
| Filing Date | Source Excerpt |
|---|---|
| 2011-04-22 | The Board believes that Mr. Cohens business experience, including his experience as an executive officer of Merck, and his service on other public company boards, combined with his business acumen and judgment provide our Board with valuable operational expertise and leadership skills. |
| 2012-04-06 | Mr. Cohen served as Senior Vice President of Merck & Co. until his retirement in January 1992 and as President of the Merck Sharp & Dohme International Division from 1977 to 1988. Since his retirement, Mr. Cohen has been active as an international business consultant. |
| 2012-11-16 | Abraham E. Cohen is listed as a director, but no software or technical qualifications are described. |
| Filing Date | Source Excerpt |
|---|---|
| 2001-09-10 | Abraham E. Cohen (65) has been Chairman of the Board since June 1994 and a director since June 1993, and is presently an independent consultant. He retired in 1992 as Senior Vice President of Merck & Co., Inc. |
| 2002-11-13 | Abraham E. Cohen (66) has been Chairman of the Board since June 1994 and a director since June 1993, and is presently an independent consultant. He retired in 1992 as Senior Vice President of Merck & Co., Inc. |
| 2003-09-23 | Mr. Cohen retired in 1992 as Senior Vice President of Merck & Co., Inc. |
| 2004-09-27 | Mr. Cohen is presently an independent consultant. He retired in 1992 as Senior Vice President of Merck & Co., Inc. |
| 2005-09-27 | Mr. Cohen retired in 1992 as Senior Vice President of Merck & Co., Inc., a position he was elected in 1985. |
| 2009-08-21 | He retired in 1992 as Senior Vice President of Merck & Co., Inc., a position he was elected to in 1985. From 1979 to 1989, Mr. Cohen was also President of Merck Sharp & Dohme International, a division of Merck & Co., Inc. Mr. Cohen is a director of the following public companies: Akzo Nobel Nv., Chugai Pharmaceutical Co., Ltd., Neurobiological Technologies, Inc. and Teva Pharmaceutical Industries, Ltd. |
Data sourced from SEC filings. Last updated: 2025-08-30